Literature DB >> 34270752

Weighing the Risks of Perimyocarditis With the Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents.

Ravi Jhaveri1,2, Felice C Adler-Shohet3,4, Christopher C Blyth5, Kathleen Chiotos6, Jeffrey S Gerber7, Michael Green8, Larry Kociolek1,2, Rachel Martin-Blais9, Debra Palazzi10, Andi L Shane11, Jennifer E Schuster12, Stanford T Shulman1,2, Gregory A Storch13, Geoffrey A Weinberg14, Theoklis Zaoutis7.   

Abstract

Entities:  

Year:  2021        PMID： 34270752     DOI： 10.1093/jpids/piab061

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


× No keyword cloud information.
  3 in total

Review 1.  Unraveling the Mystery of COVID-19 Postvaccination Myocarditis: A Systematic Review of Current Cases.

Authors:  Hamed Ghoshouni; Sara Bagherieh; Mohammad Parvizinia; Mozhde Askari; Masoumeh Sadeghi; Omid Mirmosayyeb
Journal:  Int J Clin Pract       Date:  2022-01-31       Impact factor: 3.149

2.  One Year of COVID-19 mRNA Vaccines: Incredible Progress and Unfinished Business.

Authors:  Ravi Jhaveri
Journal:  Clin Ther       Date:  2021-11-25       Impact factor: 3.393

Review 3.  Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies.

Authors:  Pedram Keshavarz; Fereshteh Yazdanpanah; Maryam Emad; Azadeh Hajati; Seyed Faraz Nejati; Faranak Ebrahimian Sadabad; Tamta Azrumelashvili; Malkhaz Mizandari; Steven S Raman
Journal:  Tomography       Date:  2022-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.